On the one hand, PGC-1α activation leads to an increase in the number of mitochondria, which inhibits CRC progression by decreasing antioxidant enzyme activity increasing oxidative stress and promoting apoptosis. Here, PPARGC1A is linked to colorectal carcinoma.